Certain New Chemicals or Significant New Uses; Statements of Findings for March, April, and May 2023, 44127-44128 [2023-14572]

Download as PDF Federal Register / Vol. 88, No. 131 / Tuesday, July 11, 2023 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Cosmetic Act (FFDCA) (21 U.S.C. 301 et seq.); the Pesticide Registration Improvement Act (PRIA) (which amends FIFRA section 33); and the Endangered Species Act (ESA) (16 U.S.C. 1531 et seq.). Potentially affected entities may include but are not limited to: Agricultural workers and farmers; pesticide industry and trade associations; environmental, consumer, and farm worker groups; pesticide users and growers; animal rights groups; pest consultants; state, local, and tribal governments; academia; public health organizations; and the public. If you have questions regarding the applicability of this action to a particular entity, consult the person listed under FOR FURTHER INFORMATION CONTACT. allowances where appropriate and according to applicable federal travel regulations. Additional information about the PPDC can be accessed at https://www.epa.gov/pesticide-advisorycommittees-and-regulatory-partners/ pesticide-program-dialogue-committeeppdc. III. Nominations In accordance with Executive Order 14035, entitled ‘‘Diversity, Equity, Inclusion, and Accessibility in the Federal Workforce’’ and dated June 25, 2021 (86 FR 34593, June 30, 2021), and consistent with law, EPA values and welcomes opportunities to increase diversity, equity, inclusion, and accessibility on its federal advisory committees. EPA’s federal advisory committees have a workforce that B. How can I get copies of this document reflects the diversity of the American and other related information? people. In an effort to obtain The docket for this action, identified nominations of diverse candidates, the by docket identification (ID) number agency encourages nominations of EPA–HQ–OPP–2023–0345, is available women and men of all racial and ethnic online at https://www.regulations.gov. groups. All nominations will be fully Additional instructions on visiting the considered, but applicants need to be docket, along with more information aware of the specific representation about dockets generally, is available at sought as outlined in the Summary https://www.epa.gov/dockets. above. Any interested person or organization may nominate qualified II. Background persons to be considered for The PPDC is a federal advisory appointment to this advisory committee. committee chartered under the Federal Individuals may self-nominate. Advisory Committee Act (FACA) (5 Nominations may be submitted in U.S.C. Appendix 2 et seq.). EPA electronic format (preferred) or mailed established the PPDC in September 1995 to Jeffrey Chang at the address listed to provide policy advice, information under ADDRESSES. and recommendations to the EPA To be considered, all nominations Administrator through the Director of should include: the Office of Pesticide Programs, Office • Current contact information for the of Chemical Safety and Pollution nominee, including the nominee’s Prevention. The PPDC provides a public name, organization (and position within forum to discuss a wide variety of that organization), current business pesticide regulatory developments and address, email address, and daytime reform initiatives, evolving public telephone number; policy and program implementation • Brief Statement describing the issues associated with evaluating and nominee’s interest and availability in reducing risks from the use of serving on the PPDC; pesticides. The EPA will consider • Re´sume´ or CV; candidates from the following sectors: • Short biography (no more than 2 environmental/public interest and paragraphs) describing the professional animal rights groups; farm worker and educational qualifications of the organizations; pesticide industry and nominee, including a list of relevant trade associations; pesticide user, activities, or any current or previous grower, and commodity groups; federal experience on advisory committees; and and state/local/tribal governments; the • Letter[s] of recommendation from a general public; academia; and public third party supporting the nomination. health organizations. The letter(s) should describe how the The PPDC usually meets face-to-face nominee’s experience and knowledge twice a year, generally in the spring and will bring value to the work of the the fall. Additionally, members may be PPDC. asked to serve on work groups to Other sources, in addition to this develop recommendations to address Federal Register notice, may also be specific policy issues. The average utilized in the solicitation of nominees. Authority: 5 U.S.C. Appendix 2 et workload for members is approximately seq., 7 U.S.C. 136 et seq., 16 U.S.C. 1531 4 to 6 hours per month. PPDC members et seq., and 21 U.S.C. 301 et seq. may receive travel and per diem VerDate Sep<11>2014 17:25 Jul 10, 2023 Jkt 259001 PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 44127 Dated: July 5, 2023. Michael Goodis, Acting Director, Office of Pesticide Programs. [FR Doc. 2023–14648 Filed 7–10–23; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPPT–2023–0098; FRL–10582– 03–OCSPP] Certain New Chemicals or Significant New Uses; Statements of Findings for March, April, and May 2023 Environmental Protection Agency (EPA). ACTION: Notice. AGENCY: The Toxic Substances Control Act (TSCA) requires EPA to publish in the Federal Register a statement of its findings after its review of certain TSCA submissions when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to premanufacture notices (PMNs), microbial commercial activity notices (MCANs), and significant new use notices (SNUNs) submitted to EPA under TSCA. This document presents statements of findings made by EPA on such submissions during the period from March 1, 2023 to May 31, 2023. ADDRESSES: The docket for this action, identified by docket identification (ID) number EPA–HQ–OPPT–2023–0098, is available online at https:// www.regulations.gov or in-person at the Office of Pollution Prevention and Toxics Docket (OPPT Docket), Environmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566–1744, and the telephone number for the OPPT Docket is (202) 566–0280. For the latest status information on EPA/DC services and docket access, visit https:// www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: For technical information contact: Rebecca Edelstein, New Chemical Division (7405M), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; telephone number: (202) 564–1667 email address: edelstein.rebecca@ epa.gov. SUMMARY: E:\FR\FM\11JYN1.SGM 11JYN1 44128 Federal Register / Vol. 88, No. 131 / Tuesday, July 11, 2023 / Notices For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 554– 1404; email address: TSCA-Hotline@ epa.gov. SUPPLEMENTARY INFORMATION: I. Executive Summary A. Does this action apply to me? This action provides information that is directed to the public in general. ddrumheller on DSK120RN23PROD with NOTICES1 B. What action is the Agency taking? This document lists the statements of findings made by EPA after review of submissions under TSCA section 5(a) that certain new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment. This document presents statements of findings made by EPA during the reporting period. C. What is the Agency’s authority for taking this action? TSCA section 5(a)(3) requires EPA to review a submission under TSCA section 5(a) and make one of several specific findings pertaining to whether the substance may present unreasonable risk of injury to health or the environment. Among those potential findings is that the chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment per TSCA Section 5(a)(3)(C). TSCA section 5(g) requires EPA to publish in the Federal Register a statement of its findings after its review of a submission under TSCA section 5(a) when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to PMNs, MCANs, and SNUNs submitted to EPA under TSCA section 5. Anyone who plans to manufacture (which includes import) a new chemical substance for a non-exempt commercial purpose and any manufacturer or processor wishing to engage in a use of a chemical substance designated by EPA as a significant new use must submit a notice to EPA at least 90 days before commencing manufacture of the new chemical substance or before engaging in the significant new use. The submitter of a notice to EPA for which EPA has made a finding of ‘‘not likely to present an unreasonable risk of injury to health or the environment’’ may commence manufacture of the chemical substance or manufacture or VerDate Sep<11>2014 17:25 Jul 10, 2023 Jkt 259001 processing for the significant new use notwithstanding any remaining portion of the applicable review period. D. Does this action have any incremental economic impacts or paperwork burdens? No. II. Statements of Findings Under TSCA Section 5(a)(3)(C) In this unit, EPA provides the following information (to the extent that such information is not claimed as Confidential Business Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this period, EPA has made findings under TSCA section 5(a)(3)(C) that the new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment: The following list provides the EPA case number assigned to the TSCA section 5(a) submission and the chemical identity (generic name if the specific name is claimed as CBI). • J–23–0004, Genetically modified microorganism for the production of a chemical substance (Generic Name). • P–22–0118, Hexanedioic acid, polymer with 1,2,3-propanetriol and 1,3,5-tris(2-hydroxyethyl)-1,3,5-triazine2,4,6(1H,3H,5H)-trione, 3-methyl-3buten-1-yl ester, CASRN 2760410–72–6. • P–22–0127, Urea, N,N′-bis-[3-[[(4methylphenyl)sulfonyl]oxy]phenyl]-, CASRN 2292123–68–1. To access EPA’s decision document describing the basis of the ‘‘not likely to present an unreasonable risk’’ finding made by EPA under TSCA section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/ reviewing-new-chemicals-under-toxicsubstances-control-act-tsca/chemicalsdetermined-not-likely. (Authority: 15 U.S.C. 2601 et seq.) Dated: July 5, 2023. Shari Barash, Acting Director, New Chemicals Division, Office of Pollution Prevention and Toxics. [FR Doc. 2023–14572 Filed 7–10–23; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY [FRL–11126–01–OW] Meeting of the National Drinking Water Advisory Council Environmental Protection Agency (EPA). ACTION: Notice of a public meeting. AGENCY: PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 The U.S. Environmental Protection Agency’s (EPA) Office of Ground Water and Drinking Water is announcing a virtual meeting of the National Drinking Water Advisory Council (NDWAC or Council) as authorized under the Safe Drinking Water Act (SDWA). The purpose of the meeting is for EPA to update the Council on Safe Drinking Water Act programs and to consult with the NDWAC as required by the SDWA on a final National Primary Drinking Water Regulation (NPDWR) for per- and polyfluoroalkyl substances (PFAS). On March 14, 2023, EPA announced the proposed National Primary Drinking Water Regulation (NPDWR) for six PFAS including perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorononanoic acid (PFNA), hexafluoropropylene oxide dimer acid (HFPO–DA, commonly known as GenX Chemicals), perfluorohexane sulfonic acid (PFHxS), and perfluorobutane sulfonic acid (PFBS). EPA proposed regulating PFOA and PFOS as individual contaminants, and PFHxS, PFNA, PFBS, and HFPO–DA (commonly referred to as GenX Chemicals) as a PFAS mixture. Additional details including other topics for discussion will be provided in the meeting agenda, which will be posted on EPA’s NDWAC website. See the SUPPLEMENTARY INFORMATION section of this announcement for more information. SUMMARY: The meeting will be held on August 8, 2023, from 10:30 a.m. to 5 p.m., eastern time. ADDRESSES: This will be a virtual meeting. There will be no in-person gathering for this meeting. For more information about attending, providing oral statements, and accessibility for the meeting, as well as sending written comments, see the SUPPLEMENTARY INFORMATION section of this announcement. DATES: FOR FURTHER INFORMATION CONTACT: Elizabeth Corr, NDWAC Designated Federal Officer, Office of Ground Water and Drinking Water (Mail Code 4601), U.S. Environmental Protection Agency, 1200 Pennsylvania Avenue NW, Washington, DC 20460; telephone number: (202) 564–3798; email address: corr.elizabeth@epa.gov. SUPPLEMENTARY INFORMATION: Attending the Meeting: The meeting will be open to the general public. The meeting agenda and information on how to register for and attend the meeting online will be provided on EPA’s website at: https://www.epa.gov/ndwac prior to the meeting. E:\FR\FM\11JYN1.SGM 11JYN1

Agencies

[Federal Register Volume 88, Number 131 (Tuesday, July 11, 2023)]
[Notices]
[Pages 44127-44128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-14572]


-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPPT-2023-0098; FRL-10582-03-OCSPP]


Certain New Chemicals or Significant New Uses; Statements of 
Findings for March, April, and May 2023

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to 
publish in the Federal Register a statement of its findings after its 
review of certain TSCA submissions when EPA makes a finding that a new 
chemical substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment. Such 
statements apply to premanufacture notices (PMNs), microbial commercial 
activity notices (MCANs), and significant new use notices (SNUNs) 
submitted to EPA under TSCA. This document presents statements of 
findings made by EPA on such submissions during the period from March 
1, 2023 to May 31, 2023.

ADDRESSES: The docket for this action, identified by docket 
identification (ID) number EPA-HQ-OPPT-2023-0098, is available online 
at https://www.regulations.gov or in-person at the Office of Pollution 
Prevention and Toxics Docket (OPPT Docket), Environmental Protection 
Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., 
Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading 
Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, 
excluding legal holidays. The telephone number for the Public Reading 
Room is (202) 566-1744, and the telephone number for the OPPT Docket is 
(202) 566-0280. For the latest status information on EPA/DC services 
and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: 
    For technical information contact: Rebecca Edelstein, New Chemical 
Division (7405M), Office of Pollution Prevention and Toxics, 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460-0001; telephone number: (202) 564-1667 email address: 
[email protected].

[[Page 44128]]

    For general information contact: The TSCA-Hotline, ABVI-Goodwill, 
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202) 
554-1404; email address: [email protected].

SUPPLEMENTARY INFORMATION: 

I. Executive Summary

A. Does this action apply to me?

    This action provides information that is directed to the public in 
general.

B. What action is the Agency taking?

    This document lists the statements of findings made by EPA after 
review of submissions under TSCA section 5(a) that certain new chemical 
substances or significant new uses are not likely to present an 
unreasonable risk of injury to health or the environment. This document 
presents statements of findings made by EPA during the reporting 
period.

C. What is the Agency's authority for taking this action?

    TSCA section 5(a)(3) requires EPA to review a submission under TSCA 
section 5(a) and make one of several specific findings pertaining to 
whether the substance may present unreasonable risk of injury to health 
or the environment. Among those potential findings is that the chemical 
substance or significant new use is not likely to present an 
unreasonable risk of injury to health or the environment per TSCA 
Section 5(a)(3)(C).
    TSCA section 5(g) requires EPA to publish in the Federal Register a 
statement of its findings after its review of a submission under TSCA 
section 5(a) when EPA makes a finding that a new chemical substance or 
significant new use is not likely to present an unreasonable risk of 
injury to health or the environment. Such statements apply to PMNs, 
MCANs, and SNUNs submitted to EPA under TSCA section 5.
    Anyone who plans to manufacture (which includes import) a new 
chemical substance for a non-exempt commercial purpose and any 
manufacturer or processor wishing to engage in a use of a chemical 
substance designated by EPA as a significant new use must submit a 
notice to EPA at least 90 days before commencing manufacture of the new 
chemical substance or before engaging in the significant new use.
    The submitter of a notice to EPA for which EPA has made a finding 
of ``not likely to present an unreasonable risk of injury to health or 
the environment'' may commence manufacture of the chemical substance or 
manufacture or processing for the significant new use notwithstanding 
any remaining portion of the applicable review period.

D. Does this action have any incremental economic impacts or paperwork 
burdens?

    No.

II. Statements of Findings Under TSCA Section 5(a)(3)(C)

    In this unit, EPA provides the following information (to the extent 
that such information is not claimed as Confidential Business 
Information (CBI)) on the PMNs, MCANs and SNUNs for which, during this 
period, EPA has made findings under TSCA section 5(a)(3)(C) that the 
new chemical substances or significant new uses are not likely to 
present an unreasonable risk of injury to health or the environment:
    The following list provides the EPA case number assigned to the 
TSCA section 5(a) submission and the chemical identity (generic name if 
the specific name is claimed as CBI).
     J-23-0004, Genetically modified microorganism for the 
production of a chemical substance (Generic Name).
     P-22-0118, Hexanedioic acid, polymer with 1,2,3-
propanetriol and 1,3,5-tris(2-hydroxyethyl)-1,3,5-triazine-
2,4,6(1H,3H,5H)-trione, 3-methyl-3-buten-1-yl ester, CASRN 2760410-72-
6.
     P-22-0127, Urea, N,N'-bis-[3-[[(4-
methylphenyl)sulfonyl]oxy]phenyl]-, CASRN 2292123-68-1.
    To access EPA's decision document describing the basis of the ``not 
likely to present an unreasonable risk'' finding made by EPA under TSCA 
section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/chemicals-determined-not-likely.

(Authority: 15 U.S.C. 2601 et seq.)

    Dated: July 5, 2023.
Shari Barash,
Acting Director, New Chemicals Division, Office of Pollution Prevention 
and Toxics.
[FR Doc. 2023-14572 Filed 7-10-23; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.